Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02110217

Ligand	Ligand name	Chain	PDB	Tanimoto
3XH	3-Hydroxyhippuric acid	A	3E9K	0.73
SHA	SALICYLHYDROXAMIC ACID	X	1V0H	0.74
SHA	SALICYLHYDROXAMIC ACID	A	2QPK	0.74
SHA	SALICYLHYDROXAMIC ACID	A	3FNL	0.74
SHA	SALICYLHYDROXAMIC ACID	A	3GCJ	0.74
SHA	SALICYLHYDROXAMIC ACID	A	1CK6	0.74
FHB	3-FLUORO-4-HYDROXYBENZOIC ACID	M,N,O,P,Q,R	3PCF	0.7
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	1L6M	0.71
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	3CBC	0.71
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	3BY0	0.71
1FL	5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID	A,B	2BXE	0.72
1FL	5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID	A,B	3D2T	0.72
BJI	1(R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	A	1ERM	0.71
BD2	3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN-4-YL 4-(2-HYDROXYBENZOYL)BENZOATE	A	1RE8	0.7
BJH	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	A	1ERQ	0.78
SGI	3-(4-hydroxyphenyl)propanamide	A,B	2R9K	0.71
HCC	2',4,4'-TRIHYDROXYCHALCONE	D	1FP1	0.71
BJP	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	A	1ERO	0.7
135	N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY-BENZAMIDE	B	1GJA	0.71
401	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	A,B	2ZNQ	0.7
DBE	bis(4-hydroxyphenyl)methanone	A	2VKU	0.7
SAL	2-HYDROXYBENZOIC ACID	A	2I2Z	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B,C	1FIQ	0.71
SAL	2-HYDROXYBENZOIC ACID	A	2I30	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	1PTH	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	3DEU	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B,C,D	2E1Q	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	3HGX	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	3BPX	0.71
SAL	2-HYDROXYBENZOIC ACID	A	1WYG	0.71
SAL	2-HYDROXYBENZOIC ACID	A	1JGS	0.71
SAL	2-HYDROXYBENZOIC ACID	X	1M6E	0.71
SAL	2-HYDROXYBENZOIC ACID	A	3B9M	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	1FO4	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	1Y7I	0.71
SAL	2-HYDROXYBENZOIC ACID	A,B	2FN1	0.71
PY9	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	A,B	3EKR	0.71
HBD	4-HYDROXYBENZAMIDE	B,C,D	1BEN	0.74
NLT	N-DODECANOYL-L-TYROSINE	A,B,C,D,E,F,G,H	2G0B	0.7
BHA	2-HYDROXY-4-AMINOBENZOIC ACID	A	1PBC	0.71
BHA	2-HYDROXY-4-AMINOBENZOIC ACID	A	1PBF	0.71
BHA	2-HYDROXY-4-AMINOBENZOIC ACID	A	1SXK	0.71
G50	3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE	A,B	2UXI	0.7
247	(3R)-3-amino-2,2-difluoro-3-(4-hydroxyphenyl)propanoic acid	A,B	2QVE	0.73
IFB	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	A,B	3FCB	0.76
EJ5	4-[3-(2-amino-4-hydroxy-6-oxo-1,6-dihydropyrimidin-5-yl)propyl]benzoic acid	X	3EJ5	0.72
DB1	2,3-DIHYDROXYBENZAMIDE	A,B,C	1X71	0.71
IFA		A,B	3FC8	0.75
SCL	ACETIC ACID SALICYLOYL-AMINO-ESTER	A	1EBV	0.77
DOB	2,4-DIHYDROXYBENZOIC ACID	A	1DOD	0.71
DOB	2,4-DIHYDROXYBENZOIC ACID	A	1DOE	0.71
DOB	2,4-DIHYDROXYBENZOIC ACID	A	1PBB	0.71
BFS	N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE	A	1STD	0.73
BFS	N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE	A,B,C	4STD	0.73